Alembic Pharma shares jump 5% on final USFDA nod to Seizure treatment drug

October 3, 2024
Uncategorized

According to IQVIA data, the market size for Lamotrigine Extended-Release tablets in these strengths is estimated to be around $163 million for the 12 months ended June 2024.

Alembic Pharma shares jump 5% on final USFDA nod to Seizure treatment drug

Leave a ReplyCancel Reply

NTPC Green Energy Q4 Results: Stock trades below IPO price ahead of earnings

Leela hotels-owner Schloss sets IPO price band for ₹3,500 crore issue

US deficit is a growing threat to global equities: Geoffrey Dennis

TCS winning a ₹2,903 crore order from BSNL leads to a major order win for Tata Group’s Tejas Networks

Rupee falls 9 paise to 85.67 against US dollar in early trade